Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Skin Testing and Drug Provocation Tests in Epidermal Necrolysis: A French Experience.
Roux C, Ben Said B, Milpied B, Bernier C, Staumont-Sallé D, Dezoteux F, Soria A, Barbaud A, Valeyrie-Allanore L, Tétart F, Bellon N, Lebrun-Vignes B, Gener G, Paul M, Ingen-Housz-Oro S, Assier H. Roux C, et al. J Allergy Clin Immunol Pract. 2022 Dec;10(12):3252-3261.e2. doi: 10.1016/j.jaip.2022.07.008. Epub 2022 Jul 20. J Allergy Clin Immunol Pract. 2022. PMID: 35870724
A three-year-analysis of fixed drug eruptions in hospital settings in France.
Brahimi N, Routier E, Raison-Peyron N, Tronquoy AF, Pouget-Jasson C, Amarger S, Machet L, Amsler E, Claeys A, Sassolas B, Leroy D, Grange A, Dupuy A, Cordel N, Bonnetblanc JM, Milpied B, Doutre MS, Guinnepain MT, Barbaud A, Chosidow O, Roujeau JC, Lebrun-Vignes B, Descamps V. Brahimi N, et al. Eur J Dermatol. 2010 Jul-Aug;20(4):461-4. doi: 10.1684/ejd.2010.0980. Epub 2010 May 27. Eur J Dermatol. 2010. PMID: 20507840
[Management of drug reaction with eosinophilia and systemic symptoms (DRESS)].
Descamps V, Ben Saïd B, Sassolas B, Truchetet F, Avenel-Audran M, Girardin P, Guinnepain MT, Mathelier-Fusade P, Assier H, Milpied B, Modiano P, Lebrun-Vignes B, Barbaud A; groupe Toxidermies de la Société française de dermatologie. Descamps V, et al. Ann Dermatol Venereol. 2010 Nov;137(11):703-8. doi: 10.1016/j.annder.2010.04.024. Epub 2010 Aug 5. Ann Dermatol Venereol. 2010. PMID: 21074653 French.
Fluindione and drug reaction with eosinophilia and systemic symptoms: an unrecognised adverse effect?
Daveluy A, Milpied B, Barbaud A, Lebrun-Vignes B, Gouraud A, Laroche ML, Ciobanu E, Bégaud B, Moore N, Miremont-Salamé G, Haramburu F; French Pharmacovigilance Centres Network and The Toxidermia Group of the French Society of Dermatology. Daveluy A, et al. Eur J Clin Pharmacol. 2012 Jan;68(1):101-5. doi: 10.1007/s00228-011-1101-9. Epub 2011 Jul 27. Eur J Clin Pharmacol. 2012. PMID: 21792562
Saliva polymerase chain reaction assay for detection and follow-up of herpesvirus reactivation in patients with drug reaction with eosinophilia and systemic symptoms (DRESS).
Descamps V, Avenel-Audran M, Valeyrie-Allanore L, Bensaid B, Barbaud A, Al Jawhari M, Ranger-Rogez S; French Study Group of Cutaneous Drug Adverse Reactions. Descamps V, et al. JAMA Dermatol. 2013 May;149(5):565-9. doi: 10.1001/jamadermatol.2013.2018. JAMA Dermatol. 2013. PMID: 23426332
[Cutaneous adverse drug reactions].
Lebrun-Vignes B, Valeyrie-Allanore L. Lebrun-Vignes B, et al. Rev Med Interne. 2015 Apr;36(4):256-70. doi: 10.1016/j.revmed.2014.10.004. Epub 2014 Nov 4. Rev Med Interne. 2015. PMID: 25458866 Free article. French.
[Fixed pigmented erythema: Epidemiology, physiopathology, clinical features, differential diagnosis and therapeutic management].
Valeyrie-Allanore L, Lebrun-Vignes B, Bensaid B, Sassolas B, Barbaub A; sous l’égide du groupe toxidermie de la Société française de dermatologie (FISARD). Valeyrie-Allanore L, et al. Ann Dermatol Venereol. 2015 Nov;142(11):701-6. doi: 10.1016/j.annder.2015.07.010. Epub 2015 Nov 6. Ann Dermatol Venereol. 2015. PMID: 26548517 French. No abstract available.
179 results